Aller au contenu principal
Accès ouvert déclaré 2026 article

Downregulation of BIRC2 attenuates high-glucose-induced injury and promotes autophagy in human glomerular mesangial cell line HGMCs

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Objective To investigate the impacts of baculovirus IAP repeat containing protein 2 (BIRC2) on mesangial cell injury and autophagy in human diabetic nephropathy (DN) in vitro. Methods Human glomerular mesangial cells HGMCs were cultured routinely and randomly divided into control group, model group, sh NC group, BIRC2 shRNA group, and BIRC2 shRNA+YC-1 group(HIF-1α inhibitor YC-1, 25 μmol/L). CCK-8 method was applied to detect the activity of HGMCs. Flow cytometry was applied to detect cell apoptosis. ELISA method was applied to detect the levels of interleukin(IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α) of cells in each group. Transmission electron microscopy was applied to observe the number of autophagosomes of cells in each group. Western blot was applied to detect the expression of BIRC2, HIF-1α/BNIP3/mTOR pathway related proteins and autophagy related protein Beclin-1, and microtubule-associated protein 1 light chain 3 (LC3) of cells in each group. Results Compared with the control group, the absorbance (A) value (48 h, 72 h), IL-1β, IL-6, TNF-α levels, BIRC2 protein expression, and mTOR phosphorylation levels of HGMCs in the model group were significantly increased(P<0.05), the apoptosis rate of HGMCs, the number of autophagosomes, and the expression levels of HIF-1α, BNIP3, Beclin-1, and LC3 Ⅱ/Ⅰ proteins were significantly reduced (P<0.05). Compared with the model group and sh NC group, the changes in the corresponding indicators of HGMCs in the BIRC2 shRNA group were opposite (P<0.05). Conclusions Downregulation of BIRC2 expression alleviates the damage of mesangial cells in human diabetic nephropathy and promotes autophagy in vitro.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

La source scientifique ouverte est momentanément indisponible.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Autophagy in Disease and TherapyAdvanced Glycation End Products researchChronic Kidney Disease and Diabetes

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.